Location History:
- Kawasaki, JP (1988)
- Kanagawa, JP (1993)
- Yokohama, JP (1991 - 1995)
- Kanagawa-ken, JP (1997 - 2000)
Company Filing History:
6 out of 32 
4 out of 382 
1 out of 1 Years Active: 1988-2000
Title: Hiroko Ogino: Innovator in Pharmaceutical Chemistry
Introduction
Hiroko Ogino is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of tricyclic benzazepine compounds. With a total of 12 patents to her name, Ogino's work has had a substantial impact on drug development.
Latest Patents
Among her latest patents are innovative compounds that serve as intermediates for pharmacologically active tricyclic benzazepine and benzothiazepine derivatives. These include triazole intermediates for tricyclic benzazepine and benzothiazepine, which are crucial for advancing therapeutic applications. The compounds of formulae (II), (III), (IV), and (V) or their salts represent a significant step forward in the synthesis of these important chemical entities.
Career Highlights
Throughout her career, Hiroko Ogino has worked with notable companies such as Meiji Seika Kabushiki Kaisha and Meiji Seika Kaisha, Ltd. Her expertise in pharmaceutical chemistry has allowed her to contribute to various projects that enhance the efficacy of medicinal compounds.
Collaborations
Ogino has collaborated with esteemed colleagues, including Takashi Tsuruoka and Kiyoaki Katano. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Hiroko Ogino's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medicine.